Is TVTX a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Travere Therapeutics Inc (TVTX) is (118.75) USD. With the latest stock price at 20.70 USD, the upside of Travere Therapeutics Inc based on DCF is -673.7%. This means that TVTX is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 9.1% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (307.44) - (76.70) | (118.75) |
| Upside | -1585.2% - -470.5% | -673.7% |